Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09PTA
|
||||
Former ID |
DIB002342
|
||||
Drug Name |
HP-290
|
||||
Synonyms |
NXX-066
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Discontinued in Phase 2 | [1] | ||
Company |
Astra AB; Hoechst AG
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C23H27N3O2
|
||||
Canonical SMILES |
[C@]12([C@@H](N(c3c1cc(OC(=O)N1Cc4c(CC1)cccc4)cc3)C)N(C<br />C2)C)C
|
||||
CAS Number |
CAS 139314-01-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [2] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
WikiPathways | Monoamine Transport | ||||
Biogenic Amine Synthesis | |||||
Acetylcholine Synthesis | |||||
Integrated Pancreatic Cancer Pathway | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006532) | ||||
REF 2 | NXX-066 in patients with Alzheimer's disease: a bridging study. Life Sci. 1999;64(14):1215-21. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.